XERS: Xeris Biopharma Holdings, Inc.
Performance
XERS +113.46%
Watchlist
Select an item
Summary
XERS at a glance
XERS returned +113.46% over the past year and +51.90% a year over five years. Its worst drop in that year was -34.93%, smaller than 47% of stocks on Redstone, and its Sharpe ratio of 1.54 beats 93% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
108.12%
Actions
Metrics
Risk Indicators
Alpha87.15%
Beta0.12x
Sharpe1.54
Sortino2.73
Omega1.33
Calmar3.25
Martin5.54
Profile
About XERS
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.9B
- Listed
- Jun 2018
- Employees
- 435
- Headquarters
- Chicago, IL
- Website
- xerispharma.com
Comparisons